Skip to content Skip to footer
Ilaris: Benefits, Reviews, Info, Side Effects!
Rx Details
Ilaris
Canakinumab
Canakinumab
Prescription
Medication
Drugs
Prescription Only
treatment of systemic juvenile idiopathic arthritis, treatment of cryopyrin-associated periodic syndromes, treatment of familial Mediterranean fever, reduction of inflammation, reduction of pain, improvement of quality of life
Diarrhea, Headache, Infections, Injection Site Reactions, Musculoskeletal Pain, Nausea, Neutropenia, Upper Respiratory Tract Infections, Vertigo, Weight Gain
Ilaris (canakinumab) is a medication used to treat certain inflammatory conditions. The dosage of Ilaris can vary depending on the specific condition being treated. Here are some typical dosages for different conditions: 1. **Cryopyrin-Associated Periodic Syndromes (CAPS):** – For adults and children aged 4 years and older, the recommended dose is 150 mg administered every 8 weeks as a subcutaneous injection. For patients weighing less than 40 kg, the dose is 2 mg/kg every 8 weeks. 2. **Systemic Juvenile Idiopathic Arthritis (SJIA):** – The recommended dose is 4 mg/kg (up to a maximum of 300 mg) administered every 4 weeks as a subcutaneous injection. 3. **Still’s Disease:** – Similar to SJIA, the recommended dose is 4 mg/kg (up to a maximum of 300 mg) every 4 weeks. It’s important to note that the exact dosage and frequency can vary based on individual patient factors, and treatment should always be guided by a healthcare professional. Always consult with a healthcare provider for the most appropriate dosage for your specific condition.
Cryopyrin-associated periodic syndromes, systemic juvenile idiopathic arthritis, gout flares
Ilaris has a generally favorable safety profile.
Interactions with other drugs that suppress the immune system
$16,000 – $20,000
$16,041.60

A Synopsis of

Ilaris

Ilaris is a medication that belongs to a class of drugs known as interleukin-1 inhibitors. It is primarily used to treat certain inflammatory conditions such as cryopyrin-associated periodic syndromes (CAPS), systemic juvenile idiopathic arthritis (SJIA), and familial Mediterranean fever (FMF). Ilaris works by blocking the action of interleukin-1, a protein in the body that is involved in the inflammatory response.

Patients who suffer from these conditions often experience symptoms such as fever, joint pain, and inflammation. Ilaris helps to reduce these symptoms and improve the overall quality of life for those affected. It is typically administered as an injection by a healthcare professional, and the dosage will vary depending on the specific condition being treated.

As with any medication, there are potential side effects associated with Ilaris. These can include injection site reactions, headaches, and upper respiratory tract infections. It is important to discuss any concerns or potential side effects with your healthcare provider before starting treatment with Ilaris.

It is also important to note that Ilaris may interact with other medications or supplements, so it is crucial to inform your healthcare provider of all medications you are currently taking before starting Ilaris. Additionally, pregnant or breastfeeding women should consult with their healthcare provider before using Ilaris.

Overall, Ilaris has been shown to be an effective treatment option for certain inflammatory conditions, providing relief for patients who suffer from these chronic conditions. If you believe you may benefit from Ilaris, speak with your healthcare provider to determine if it is the right treatment option for you.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN